TSLP, IL-33, and IL-25: Not just for allergy and helminth infection

J Allergy Clin Immunol. 2022 Dec;150(6):1302-1313. doi: 10.1016/j.jaci.2022.07.003. Epub 2022 Jul 19.

Abstract

The release of cytokines from epithelial and stromal cells is critical for the initiation and maintenance of tissue immunity. Three such cytokines, thymic stromal lymphopoietin, IL-33, and IL-25, are important regulators of type 2 immune responses triggered by parasitic worms and allergens. In particular, these cytokines activate group 2 innate lymphoid cells, TH2 cells, and myeloid cells, which drive hallmarks of type 2 immunity. However, emerging data indicate that these tissue-associated cytokines are not only involved in canonical type 2 responses but are also important in the context of viral infections, cancer, and even homeostasis. Here, we provide a brief review of the roles of thymic stromal lymphopoietin, IL-33, and IL-25 in diverse immune contexts, while highlighting their relative contributions in tissue-specific responses. We also emphasize a biologically motivated framework for thinking about the integration of multiple immune signals, including the 3 featured in this review.

Keywords: Cytokines; allergy; cancer; helminth; tissue immunity; viral infection.

Publication types

  • Review

MeSH terms

  • Helminthiasis* / immunology
  • Humans
  • Hypersensitivity* / immunology
  • Immunity, Innate
  • Interleukin-17*
  • Interleukin-33*
  • Lymphocytes
  • Thymic Stromal Lymphopoietin*

Substances

  • Interleukin-33
  • IL25 protein, human
  • TSLP protein, human
  • Interleukin-17
  • Thymic Stromal Lymphopoietin